Lpl Financial LLC Verastem, Inc. Transaction History

Lpl Financial LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.92 - $11.16 $1,251 - $15,177	1,360 Added 10.62%	14,169 $12,000
Q2 2022 Aug 12, 2022	BUY	$1.02 - $1.83 $192 - $345	189 Added 1.5%	12,809 $15,000
Q1 2022 May 16, 2022	BUY	$1.06 - $2.1 $86 - $172	82 Added 0.65%	12,620 $18,000
Q4 2021 Feb 14, 2022	BUY	$2.05 - $3.2 $25,702 - $40,121	12,538 New	12,538 $26,000
Q3 2020 Nov 09, 2020	SELL	$1.11 - $1.68 $11,366 - $17,203	-10,240 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$1.69 - $4.2 $17,305 - $43,008	10,240 New	10,240 $18,000
Q4 2017 Feb 14, 2018	SELL	$2.99 - $4.85 $58,287 - $94,545	-19,494 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	19,494	19,494 $42,000

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $1.09B
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Lpl Financial LLC with notifications on news.